ATLAS Biolabs and Ingenuity® Systems have signed a collaboration agreement that gives ATLAS Biolabs’ customers the option to analyse and interpret their study data using Ingenuity solutions.
Ingenuity Variant Analysis will be used to identify causal variants from the output of whole genome and exome sequencing experiments and iReport will be used for the biological interpretation of RNA-Seq and other gene expression data.
Both solutions leverage the Ingenuity Knowledge Base, a repository of biological interactions and functional annotations created from millions of individually modelled relationships between proteins, genes, complexes, cells, tissues, metabolites, drugs, and diseases.
By offering the Ingenuity products, ATLAS Biolabs supports the complete workflow from project design to scientific analysis, providing its customers with high-quality laboratory and bioinformatic services.
“The Ingenuity products facilitate and accelerate the bioinformatics support we provide to our customers. They allow us and our customer to interactively manoeuvre through the data and shed light on it from multiple biological perspectives to understand the biological meaning.” explains Dr. Karsten R. Heidtke, Head of Bioinformatics at ATLAS Biolabs.
“We are very pleased to partner with ATLAS Biolabs in Europe to offer a complete ‘sample to insight’ solution to ATLAS Biolabs’ customers combining ATLAS Biolabs’ lab services with Ingenuity’s analysis and biological interpretation solution,” stated Sean Scott, Sr. Vice President, Global Commercial Operations, Ingenuity Systems.
“By providing Ingenuity iReport and Ingenuity Variant Analysis, ATLAS Biolabs can support researchers working with RNA-Seq and DNA resequencing data, so that they can quickly and reliably understand the underlying biology of their experiments.”
About Ingenuity Systems
Ingenuity Systems is a leading provider of information and analysis solutions for life science researchers, computational biologists, bioinformaticists, and life science industry suppliers. For more information visit: www.ingenuity.com.
About ATLAS Biolabs GmbH
ATLAS Biolabs GmbH is a leading provider of complex analyses in molecular genetics, including microarray-based genomic services, targeted sequence capture and next generation sequencing in Europe. The company has access to the next generation sequencing and microarray platforms of all leading suppliers in this field (Affymetrix, Agilent, Illumina and Roche NimbleGen, Sequenom) and is a Certified Affymetrix, Agilent and Roche NimbleGen Service Provider.
Based in Germany, ATLAS Biolabs started its business operations in August 2007. Its production processes are subject to rigorous quality control at all steps according to the international standards ISO 9001:2008 and ISO 13485:2003. Customers of ATLAS Biolabs include academic institutions, pharmaceutical and biotechnological enterprises, clinicians and registered physicians both in Germany and abroad. For more information, please visit www.atlas-biolabs.com.